David Shapiro, Chief Medical Officer at INTERCEPT PHARMACEUTICALS, INC. (ICPT), sold 6,850 shares at $102.95 ($705K) on 2018-10-15, disclosed to the SEC on 2018-10-16.
Seasonal sale ($705k) by Chief Medical Officer — this insider has traded ICPT in October in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $102.95 | 3,425 | $353K | 50.0% |
| 2 | $102.95 | 3,425 | $353K | 50.0% |
| Total | $102.95 avg | 6,850 | $705K | 100% |
| Filing → |
| ICPT | SELL | 2019-04-03 | $129K | — | Filing → |
| ICPT | SELL | 2019-03-01 | $206K | — | Filing → |
| ICPT | SELL | 2019-02-20 | $223K | — | Filing → |